Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Orthomyxoviridae | 6 | 2019 | 1168 | 1.38 | Why? |
| Neuraminidase | 2 | 2019 | 289 | 1.10 | Why? |
| Influenzavirus B | 1 | 2019 | 56 | 0.81 | Why? |
| Influenza Vaccines | 5 | 2019 | 2941 | 0.76 | Why? |
| Influenza A Virus, H1N1 Subtype | 3 | 2019 | 2984 | 0.73 | Why? |
| Vaccines, Attenuated | 3 | 2018 | 952 | 0.70 | Why? |
| Adaptation, Physiological | 1 | 2021 | 359 | 0.70 | Why? |
| Influenza A virus | 3 | 2019 | 2234 | 0.67 | Why? |
| Cell Cycle Proteins | 1 | 2019 | 297 | 0.67 | Why? |
| Nerve Tissue Proteins | 1 | 2019 | 319 | 0.66 | Why? |
| Enzyme Assays | 1 | 2018 | 295 | 0.64 | Why? |
| Nuclear Proteins | 1 | 2019 | 321 | 0.64 | Why? |
| Respiratory System | 3 | 2021 | 3213 | 0.61 | Why? |
| RNA-Binding Proteins | 2 | 2021 | 1022 | 0.58 | Why? |
| Cell Culture Techniques | 1 | 2019 | 704 | 0.56 | Why? |
| Furin | 1 | 2021 | 1054 | 0.52 | Why? |
| Viral Proteins | 4 | 2021 | 7370 | 0.52 | Why? |
| Drug Resistance, Viral | 1 | 2018 | 1083 | 0.46 | Why? |
| Influenza, Human | 6 | 2019 | 10779 | 0.45 | Why? |
| Genetics, Microbial | 1 | 2010 | 9 | 0.44 | Why? |
| Influenza A Virus, H5N1 Subtype | 2 | 2019 | 492 | 0.43 | Why? |
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2013 | 511 | 0.38 | Why? |
| Immunity, Humoral | 2 | 2021 | 4849 | 0.37 | Why? |
| Ferrets | 3 | 2021 | 1201 | 0.35 | Why? |
| Influenza in Birds | 1 | 2013 | 528 | 0.34 | Why? |
| Virus Replication | 10 | 2021 | 14331 | 0.34 | Why? |
| Pyrazines | 1 | 2018 | 1783 | 0.34 | Why? |
| Amides | 1 | 2018 | 1864 | 0.33 | Why? |
| Madin Darby Canine Kidney Cells | 2 | 2019 | 640 | 0.32 | Why? |
| Point Mutation | 2 | 2019 | 481 | 0.31 | Why? |
| Influenza B virus | 2 | 2019 | 815 | 0.30 | Why? |
| Chiroptera | 1 | 2019 | 3530 | 0.26 | Why? |
| Animals | 14 | 2021 | 78931 | 0.23 | Why? |
| Mutation | 2 | 2021 | 12376 | 0.23 | Why? |
| Anoctamins | 1 | 2021 | 22 | 0.23 | Why? |
| Dogs | 2 | 2019 | 2529 | 0.22 | Why? |
| Orthomyxoviridae Infections | 2 | 2018 | 1001 | 0.21 | Why? |
| Immune Evasion | 2 | 2021 | 2081 | 0.21 | Why? |
| Cathepsins | 1 | 2021 | 204 | 0.21 | Why? |
| Cell Fusion | 1 | 2021 | 400 | 0.20 | Why? |
| Spike Glycoprotein, Coronavirus | 5 | 2021 | 37182 | 0.19 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.19 | Why? |
| Disease Models, Animal | 5 | 2020 | 10998 | 0.19 | Why? |
| Giant Cells | 1 | 2021 | 334 | 0.18 | Why? |
| Epithelium | 1 | 2020 | 330 | 0.18 | Why? |
| Lysine | 1 | 2018 | 153 | 0.18 | Why? |
| Epithelial Cells | 2 | 2021 | 3508 | 0.17 | Why? |
| Endosomes | 1 | 2021 | 490 | 0.17 | Why? |
| Gene Expression | 2 | 2018 | 3332 | 0.17 | Why? |
| Protein Stability | 1 | 2019 | 756 | 0.16 | Why? |
| Enzyme Activation | 1 | 2018 | 425 | 0.16 | Why? |
| Antibodies, Neutralizing | 2 | 2020 | 25288 | 0.16 | Why? |
| A549 Cells | 2 | 2019 | 2066 | 0.16 | Why? |
| Genes, Reporter | 1 | 2018 | 472 | 0.16 | Why? |
| Antibodies, Viral | 8 | 2021 | 51949 | 0.16 | Why? |
| Arginine | 1 | 2018 | 377 | 0.15 | Why? |
| Tracheotomy | 1 | 2021 | 427 | 0.15 | Why? |
| Protein Subunits | 1 | 2018 | 755 | 0.15 | Why? |
| Hydrogen-Ion Concentration | 1 | 2019 | 993 | 0.15 | Why? |
| Immunoassay | 2 | 2021 | 4485 | 0.14 | Why? |
| London | 1 | 2021 | 2166 | 0.14 | Why? |
| Immune Tolerance | 1 | 2019 | 608 | 0.14 | Why? |
| Myxovirus Resistance Proteins | 1 | 2013 | 77 | 0.13 | Why? |
| Disease Transmission, Infectious | 1 | 2017 | 9044 | 0.13 | Why? |
| Mice | 4 | 2020 | 21357 | 0.12 | Why? |
| Virus Internalization | 2 | 2021 | 7921 | 0.12 | Why? |
| Transcription, Genetic | 1 | 2018 | 1326 | 0.11 | Why? |
| Humans | 27 | 2021 | 930598 | 0.11 | Why? |
| Membrane Proteins | 1 | 2021 | 1733 | 0.10 | Why? |
| Recurrence | 1 | 2020 | 3675 | 0.10 | Why? |
| CRISPR-Cas Systems | 1 | 2019 | 1397 | 0.10 | Why? |
| Seroconversion | 1 | 2020 | 2515 | 0.10 | Why? |
| Microbial Sensitivity Tests | 1 | 2018 | 2886 | 0.10 | Why? |
| Drug Evaluation, Preclinical | 1 | 2021 | 3347 | 0.09 | Why? |
| Cell Line | 3 | 2021 | 12040 | 0.09 | Why? |
| Single-Cell Analysis | 1 | 2019 | 2450 | 0.09 | Why? |
| Cells, Cultured | 2 | 2018 | 5835 | 0.09 | Why? |
| Disease Outbreaks | 1 | 2017 | 27595 | 0.09 | Why? |
| DNA, Complementary | 1 | 2010 | 568 | 0.09 | Why? |
| RNA, Viral | 6 | 2021 | 32276 | 0.09 | Why? |
| Nanoparticles | 1 | 2020 | 2040 | 0.09 | Why? |
| Molecular Sequence Data | 1 | 2013 | 3198 | 0.09 | Why? |
| Chickens | 1 | 2013 | 1010 | 0.08 | Why? |
| Vero Cells | 2 | 2021 | 14117 | 0.08 | Why? |
| Communicable Disease Control | 1 | 2017 | 29620 | 0.08 | Why? |
| Immunologic Memory | 1 | 2019 | 3362 | 0.08 | Why? |
| Zoonoses | 1 | 2021 | 3034 | 0.08 | Why? |
| Antigens, Viral | 2 | 2021 | 6298 | 0.08 | Why? |
| Antiviral Agents | 2 | 2019 | 41703 | 0.08 | Why? |
| Protein Domains | 1 | 2019 | 6563 | 0.08 | Why? |
| Base Sequence | 1 | 2013 | 3581 | 0.07 | Why? |
| Serine Endopeptidases | 1 | 2021 | 4606 | 0.07 | Why? |
| Pneumonia, Viral | 4 | 2021 | 243684 | 0.07 | Why? |
| Genes, Viral | 1 | 2010 | 1428 | 0.07 | Why? |
| Virus Shedding | 1 | 2021 | 5834 | 0.07 | Why? |
| Immunogenicity, Vaccine | 1 | 2019 | 4624 | 0.07 | Why? |
| T-Lymphocytes | 1 | 2021 | 6670 | 0.06 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.06 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.06 | Why? |
| Host-Pathogen Interactions | 2 | 2019 | 11041 | 0.06 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.06 | Why? |
| Chloride Channels | 1 | 2021 | 51 | 0.06 | Why? |
| Amino Acid Sequence | 1 | 2013 | 6049 | 0.06 | Why? |
| Interferons | 1 | 2013 | 2885 | 0.05 | Why? |
| Seroepidemiologic Studies | 3 | 2021 | 10017 | 0.05 | Why? |
| Calcium Signaling | 1 | 2021 | 133 | 0.05 | Why? |
| Enzyme-Linked Immunospot Assay | 1 | 2021 | 325 | 0.05 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.05 | Why? |
| England | 2 | 2021 | 5116 | 0.05 | Why? |
| Viral Vaccines | 1 | 2020 | 7560 | 0.05 | Why? |
| Active Transport, Cell Nucleus | 1 | 2019 | 203 | 0.05 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2020 | 8843 | 0.05 | Why? |
| Phenylurea Compounds | 1 | 2019 | 101 | 0.04 | Why? |
| HIV-1 | 1 | 2013 | 3365 | 0.04 | Why? |
| Computational Biology | 1 | 2013 | 4514 | 0.04 | Why? |
| Urea | 1 | 2019 | 228 | 0.04 | Why? |
| Caco-2 Cells | 1 | 2021 | 1236 | 0.04 | Why? |
| Health Policy | 1 | 2017 | 6242 | 0.04 | Why? |
| Pregnancy | 1 | 2019 | 23879 | 0.04 | Why? |
| Time Factors | 1 | 2020 | 31397 | 0.04 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Antibody-Dependent Enhancement | 1 | 2020 | 413 | 0.04 | Why? |
| RNA Interference | 1 | 2019 | 534 | 0.04 | Why? |
| Genome, Viral | 1 | 2018 | 13157 | 0.04 | Why? |
| Delivery of Health Care | 1 | 2021 | 15909 | 0.04 | Why? |
| Phylogeny | 1 | 2013 | 13341 | 0.03 | Why? |
| RNA, Small Interfering | 1 | 2019 | 817 | 0.03 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.03 | Why? |
| Global Health | 1 | 2017 | 13911 | 0.03 | Why? |
| Virus Integration | 1 | 2013 | 96 | 0.03 | Why? |
| Female | 8 | 2021 | 380317 | 0.03 | Why? |
| Pyridines | 1 | 2019 | 680 | 0.03 | Why? |
| Alveolar Epithelial Cells | 1 | 2021 | 1445 | 0.03 | Why? |
| Virion | 1 | 2020 | 1444 | 0.03 | Why? |
| Substrate Specificity | 1 | 2013 | 639 | 0.03 | Why? |
| RNA Viruses | 1 | 2019 | 824 | 0.03 | Why? |
| Cell Nucleus | 1 | 2013 | 399 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.03 | Why? |
| Reverse Transcription | 1 | 2013 | 673 | 0.03 | Why? |
| Minority Groups | 1 | 2021 | 1631 | 0.03 | Why? |
| DNA, Viral | 1 | 2020 | 2521 | 0.02 | Why? |
| Mice, Inbred BALB C | 1 | 2020 | 5814 | 0.02 | Why? |
| Species Specificity | 1 | 2013 | 1356 | 0.02 | Why? |
| Protein Kinase Inhibitors | 1 | 2019 | 1585 | 0.02 | Why? |
| Adult | 6 | 2021 | 244371 | 0.02 | Why? |
| Risk | 1 | 2021 | 5288 | 0.02 | Why? |
| HIV Infections | 1 | 2013 | 11620 | 0.02 | Why? |
| Vaccines, Synthetic | 1 | 2020 | 3231 | 0.02 | Why? |
| Immunity, Cellular | 1 | 2020 | 3614 | 0.02 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.02 | Why? |
| Middle Aged | 5 | 2021 | 270681 | 0.02 | Why? |
| Intubation, Intratracheal | 1 | 2021 | 3962 | 0.02 | Why? |
| Seasons | 1 | 2018 | 4071 | 0.02 | Why? |
| Public Health Surveillance | 1 | 2018 | 3129 | 0.02 | Why? |
| Population Surveillance | 1 | 2021 | 4967 | 0.02 | Why? |
| Mortality | 1 | 2021 | 7132 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.02 | Why? |
| Male | 5 | 2021 | 367725 | 0.02 | Why? |
| Follow-Up Studies | 1 | 2020 | 17020 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2021 | 11367 | 0.01 | Why? |
| Lung | 2 | 2021 | 31049 | 0.01 | Why? |
| United Kingdom | 1 | 2021 | 18046 | 0.01 | Why? |
| Aged | 3 | 2021 | 215776 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.01 | Why? |
| Prevalence | 1 | 2021 | 25773 | 0.01 | Why? |
| Cytokines | 1 | 2020 | 15010 | 0.01 | Why? |
| Risk Assessment | 1 | 2018 | 25439 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2021 | 88759 | 0.01 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.01 | Why? |
| Adolescent | 1 | 2021 | 86841 | 0.01 | Why? |
| Young Adult | 1 | 2021 | 93724 | 0.01 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |
| Retrospective Studies | 1 | 2020 | 105322 | 0.01 | Why? |
Barclay's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(175)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(191)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_